Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Psychiatr Serv ; 72(9): 1026-1030, 2021 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-33882689

RESUMEN

OBJECTIVE: Civilians who survive wartime attacks commonly experience substantial psychological distress, including acute stress reactions (ASRs) and posttraumatic stress disorder (PTSD). The authors sought to determine the level of Israeli civilian exposure to wartime attacks, prevalence of posttraumatic stress disorder (PTSD) and physical injuries, and associated medical costs over a 7-year period. METHODS: Data from the National Insurance Institute of Israel on civilian survivors of wartime attacks in the 2009-2015 period were retrospectively examined. RESULTS: Overall, 11,476 civilians were affected by 243 wartime attacks during the study period. Of these individuals, 7,561 (65.9%) received early intervention (EI) psychological treatment for ASRs, 1,332 (11.6%) were subsequently adjudicated as having a disability (all causes), and 519 (4.5%) were adjudicated as disabled by PTSD through the end of 2016. Individuals who received immediate ASR treatment were less likely to be disabled by PTSD (p=0.001). Among those without physical injuries, the EI was associated with decreased PTSD disability (2.6% of those receiving the EI developed PTSD, whereas 7.2% of those who did not receive the EI developed PTSD); however, for those with physical injuries, the PTSD rate was higher among those who received the EI (30.4%) than among those who did not receive the EI (5.2%). Individuals having a disability other than PTSD incurred higher medical costs ($7,153 in 2016 U.S. dollars) than individuals with PTSD ($1,960). CONCLUSIONS: An approach of providing case management, medical care, behavioral health screening, and EI for ASRs in the wake of wartime attacks on civilians minimized long-term PTSD-related disability.


Asunto(s)
Trastornos por Estrés Postraumático , Humanos , Israel/epidemiología , Prevalencia , Estudios Retrospectivos , Trastornos por Estrés Postraumático/epidemiología , Trastornos por Estrés Postraumático/terapia , Sobrevivientes
2.
Isr J Psychiatry Relat Sci ; 50(3): 210-6, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24622481

RESUMEN

AIM: This paper examines symptoms of anxiety and depression of Holocaust survivors' (HS) offspring as a function of their parents' age, gender, and survival situation (whether the survivor parent was alone or with a relative during the war). METHOD: The 180 adults (142 with two parent survivors; 38 with a single parent survivor) who participated in this study completed (a) a measure of state-trait anxiety, (b) a measure of depression symptoms, (c) a sociodemographic questionnaire was divided into three sections: information about the participant, about his mother and about his father. RESULTS: Participants whose mothers were aged 18 or younger during the war and survived alone report more symptoms of anxiety and depression than participants whose mothers were the same age yet survived in the company of relatives. Participants whose mothers were aged 19 or older and survived either alone or in the company of relatives, exhibited fewer symptoms of anxiety and depression. The survival situation was the only predictor related to the fathers. There were no significant differences between participants with one or two HS parents. DISCUSSION: Although this study is based on a relatively small sample, it highlights the relationship between the parents' survival situation and symptoms of anxiety and depression among their offspring.


Asunto(s)
Hijos Adultos/psicología , Ansiedad/psicología , Depresión/psicología , Holocausto/psicología , Padres/psicología , Sobrevivientes/psicología , Adulto , Factores de Edad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven
3.
Isr J Psychiatry Relat Sci ; 45(3): 177-82, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19398821

RESUMEN

BACKGROUND: The psychiatric sequelae of childhood sexual abuse (CSA) is associated with a variety of psychiatric disorders, such as eating disorders, depression, posttraumatic-stress disorder and borderline personality disorder. This study examined the association of CSA and obsessive-compulsive disorder (OCD) in adults. METHODS: Frequency of CSA was examined among 30 OCD patients and in two control groups: 17 patients with panic disorder (PD) and 26 non-psychiatric rheumatic patients (NPRP). Study tool was a semi-structured interview. RESULTS: A significantly higher frequency of CSA involving physical contact was found among the OCD (53.3%) and PD patients (52.9%) as compared to NPRP (23.1%). No significant differences were found in the frequencies of non-contact CSA. LIMITATIONS: Differences could partially be attributed to the tendency of psychiatric patients to provide personal information, especially when motivated to pinpoint an external factor for their illness. CONCLUSIONS: A positive association was found between contact-CSA and OCD as well as PD.While it is not definitely clear whether CSA is a unique entity or has influence similar to any other stressful life event, the findings of this study support further investigation of the role of contact CSA in OCD and PD, as well as in other psychiatric disorders.


Asunto(s)
Abuso Sexual Infantil/psicología , Trastorno Obsesivo Compulsivo/epidemiología , Trastorno Obsesivo Compulsivo/psicología , Trastorno de Pánico/psicología , Adulto , Estudios de Casos y Controles , Niño , Abuso Sexual Infantil/diagnóstico , Comorbilidad , Femenino , Humanos , Masculino , Trastorno Obsesivo Compulsivo/diagnóstico , Trastorno de Pánico/diagnóstico , Trastorno de Pánico/epidemiología , Escalas de Valoración Psiquiátrica , Enfermedades Reumáticas/psicología
4.
J Clin Psychiatry ; 67(6): 882-9, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16848647

RESUMEN

OBJECTIVE: A 20-month prospective follow-up of survivors of the severe earthquake in Turkey in 1999 examined the natural course of posttraumatic stress disorder (PTSD) and the contribution of different symptom clusters to the emergence of PTSD. METHOD: Subjects were randomly sampled in a suburb of Istanbul that was severely affected by the earthquake. A total of 464 adults were assessed with a self-report instrument for PTSD symptoms on 3 consecutive surveys that were administered 1 to 3, 6 to 10, and 18 to 20 months following the earthquake. RESULTS: The prevalence of PTSD was 30.2% on the first survey and decreased to 26.9% and 10.6% on the second and third surveys, respectively. Female subjects showed initially higher (34.8%) PTSD rates compared with male subjects (19.1%). However, gender differences disappeared by the time of the third survey due to high spontaneous remission rates in female subjects. Low levels of chronic and delayed-onset PTSD were observed. A major contribution of the avoidance symptoms to PTSD diagnosis was identified by statistical analysis. CONCLUSIONS: Initial PTSD following an earthquake may be as prevalent as in other natural disasters, but high rates of spontaneous remission lead to low prevalence 1.5 years following the earthquake. Initial avoidance characteristics play a major role in the emergence of PTSD.


Asunto(s)
Desastres , Trastornos por Estrés Postraumático/psicología , Sobrevivientes/psicología , Adulto , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Prospectivos , Factores Sexuales , Trastornos por Estrés Postraumático/epidemiología , Trastornos por Estrés Postraumático/etnología , Turquía/epidemiología
5.
Psychiatry Res ; 135(2): 145-52, 2005 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-15922457

RESUMEN

This report documents emerging posttraumatic obsessive-compulsive disorder in 13 Israeli military veterans diagnosed with both obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD), for whom the onset of OCD was clearly associated with the trauma. Data presented include four detailed case reports that delineate relations between symptomatology in the two disorders. Clinical and theoretical implications of these data are discussed.


Asunto(s)
Personal Militar/psicología , Personal Militar/estadística & datos numéricos , Trastorno Obsesivo Compulsivo/complicaciones , Trastornos por Estrés Postraumático/complicaciones , Veteranos/psicología , Veteranos/estadística & datos numéricos , Adulto , Trastornos de Ansiedad/diagnóstico , Trastornos de Ansiedad/psicología , Terapia Combinada , Quimioterapia , Humanos , Masculino , Persona de Mediana Edad , Trastorno Obsesivo Compulsivo/diagnóstico , Trastorno Obsesivo Compulsivo/terapia , Psicoterapia , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/terapia
6.
Eur Neuropsychopharmacol ; 15(3): 279-82, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15820416

RESUMEN

BACKGROUND: Several lines of evidence point to serotonergic abnormalities in patients with panic disorder (PD). Our goal was to further examine central serotonergic function in panic patients using autonomic and subjective responses to the postsynaptic serotonin 5-HT1D receptor agonist Sumatriptan. METHOD: Using a double-blind, randomized, placebo-controlled design, we assessed autonomic and subjective responses to oral Sumatriptan (100 mg) and placebo in 15 patients with PD, free of medication. Subjective responses were measured using the Hamilton Anxiety Rating Scale (HAM-A), National Institute of Mental Health Anxiety Scale (NIMHA), a modified version of the Panic Symptom Inventory (PI), Hamilton Depression Rating Scale (HAM-D), and Montgomery-Asberg Depression Rating Scale (MADRS). RESULTS: PD patients exhibited significantly enhanced autonomic and subjective responses following challenge with Sumatriptan. We observed an increased pulse rate and augmentation of various parameters measured on different anxiety scales. A constant inclination of aggravation of the measured parameters was detected during the hour post challenge. CONCLUSION: Oral administration of Sumatriptan, a 5-HT1D agonist, has been associated with an anxiogenic effect in PD patients.


Asunto(s)
Trastorno de Pánico/tratamiento farmacológico , Agonistas de Receptores de Serotonina/farmacología , Sumatriptán/farmacología , Adolescente , Adulto , Presión Sanguínea/efectos de los fármacos , Método Doble Ciego , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Trastorno de Pánico/fisiopatología , Trastorno de Pánico/psicología , Escalas de Valoración Psiquiátrica
7.
Neuropsychobiology ; 50(3): 200-5, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15365215

RESUMEN

We have conducted a pharmacological challenge experiment in 10 medication-free obsessive compulsive (OC) disorder (OCD) patients. We used a placebo-controlled paradigm for m-chlorophenylpiperazine (mCPP) and sumatriptan challenges. Endocrine, physiological and behavioral variables were assessed at baseline and over a 3-hour period after the challenge. Both cortisol and prolactin were significantly elevated in OCD patients following mCPP administration. Both mCPP and sumatriptan caused significant OC symptom exacerbation with the response to sumatriptan being more robust. We conclude that the 5-HT(1Dbeta) receptor may play a role in the pathophysiology of OCD.


Asunto(s)
Trastorno Obsesivo Compulsivo/fisiopatología , Piperazinas , Receptor de Serotonina 5-HT1B/fisiología , Agonistas de Receptores de Serotonina , Sumatriptán , Adulto , Femenino , Humanos , Hidrocortisona/sangre , Masculino , Persona de Mediana Edad , Placebos , Prolactina/sangre
8.
Psychiatry Res ; 124(2): 87-103, 2003 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-14561427

RESUMEN

A pertinent question in biological psychiatry is what differentiates responders and non-responders to pharmacological treatment. One possibility is that individual differences in the symptomatic spectrum as well as in the underlying biology of the disorder lead to the known 40% failure in pharmacological treatment. Our study aimed to maximize individual brain markers of obsessive-compulsive disorder (OCD) by applying single photon emission computed tomography (SPECT) during a provoked symptomatic state prior to and following treatment. Four brain SPECT scans were obtained from 26 OCD patients prior to and at 6 months of sertraline treatment. At each time point, two SPECT scans were performed in a counterbalanced order of two specific states; one a symptom-provoking condition and the other a relaxed condition. At 6 months of treatment, patients were divided into responders and non-responders according to a predetermined clinical criterion. Prospective responders showed significantly lower brain perfusion in the dorsal-caudal anterior cingulum and higher brain perfusion in the right caudate, when compared to non-responders, only during symptom provocation. When pre- and post-treatment scans during symptom provocation were compared, only responders showed significant change in brain response: increased perfusion in the left anterior temporal cortex and prefrontal cortex at 6 months' treatment. These findings suggest that obtaining functional brain imaging during specific symptom provocation emphasizes individual differences in brain reactivity. Thus can indicate prospective responders to symptom-related treatment in OCD and mark the relevant brain regions for effective response to treatment.


Asunto(s)
Nivel de Alerta/fisiología , Corteza Cerebral/irrigación sanguínea , Giro del Cíngulo/irrigación sanguínea , Trastorno Obsesivo Compulsivo/diagnóstico por imagen , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Sertralina/uso terapéutico , Tomografía Computarizada de Emisión de Fotón Único , Adulto , Nivel de Alerta/efectos de los fármacos , Núcleo Caudado/irrigación sanguínea , Núcleo Caudado/diagnóstico por imagen , Núcleo Caudado/efectos de los fármacos , Corteza Cerebral/diagnóstico por imagen , Corteza Cerebral/efectos de los fármacos , Señales (Psicología) , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Giro del Cíngulo/diagnóstico por imagen , Giro del Cíngulo/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Trastorno Obsesivo Compulsivo/tratamiento farmacológico , Trastorno Obsesivo Compulsivo/fisiopatología , Inventario de Personalidad , Pronóstico , Flujo Sanguíneo Regional/efectos de los fármacos , Flujo Sanguíneo Regional/fisiología , Inhibidores Selectivos de la Recaptación de Serotonina/efectos adversos , Sertralina/efectos adversos , Resultado del Tratamiento
9.
Int J Neuropsychopharmacol ; 6(2): 139-44, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12890307

RESUMEN

Comorbidity in bipolar disorder is the rule rather than the exception more than 60% of bipolar patients have a comorbid diagnosis and is associated with a mixed affective or dysphoric state; high rates of suicidality; less favourable response to lithium and poorer overall outcome. There is convincing evidence that rates of substance use and anxiety disorders are higher among patients with bipolar disorder compared to their rates in the general population. The interaction between anxiety disorders and substance use goes both ways: patients with bipolar disorder have a higher rate of substance use and anxiety disorder, and vice versa. Bipolar disorder is also associated with borderline personality disorder and ADHD, and to a lesser extent with weight gain. As more than 40% of bipolar patients have anxiety disorder, it is indicated that while diagnosing bipolar patients, systematic enquiry about different anxiety disorders is called for. This also presents a therapeutic challenge, since agents that effectively treat anxiety disorders are associated with the risk of induced mania. Therefore, the treating psychiatrist needs to carefully evaluate the potential benefit of treating the anxiety against the potential cost of inducing a manic episode. A possible solution would be to use, when possible, a non-pharmacological intervention, such as a cognitivebehavioural approach. Alternately, it is suggested that the clinician attempts to ensure that the patient receives adequate treatment with mood stabilizers before slowly and carefully attempting the addition of anti-anxiety compounds with a relatively lower risk of mania induction (e.g. SSRIs compared to TCAs).


Asunto(s)
Trastorno Bipolar/complicaciones , Ansiedad/complicaciones , Ansiedad/psicología , Trastorno por Déficit de Atención con Hiperactividad/complicaciones , Trastorno por Déficit de Atención con Hiperactividad/psicología , Trastorno Bipolar/diagnóstico , Trastorno Bipolar/epidemiología , Trastorno Bipolar/terapia , Trastorno de Personalidad Limítrofe/complicaciones , Trastorno de Personalidad Limítrofe/psicología , Humanos , Obesidad/complicaciones , Obesidad/psicología , Trastorno Obsesivo Compulsivo/complicaciones , Trastorno Obsesivo Compulsivo/psicología , Trastorno de Pánico/complicaciones , Trastorno de Pánico/psicología , Trastornos Fóbicos/complicaciones , Trastornos Fóbicos/psicología , Escalas de Valoración Psiquiátrica , Trastornos Relacionados con Sustancias/complicaciones , Trastornos Relacionados con Sustancias/psicología
10.
J Clin Psychiatry ; 63 Suppl 6: 20-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12027116

RESUMEN

Nonresponse to treatment in obsessive-compulsive disorder is common, associated with substantial impairment, and understudied. Little practical advice is available to clinicians on next-step treatment strategies for patients who have not responded well to 2 trials of selective serotonin reuptake inhibitors (SSRIs). Available options include continuation of SSRI treatment, switching to another SSRI or selective serotonin-norepinephrine reuptake inhibitor, augmenting with atypical neuroleptics or cognitive-behavioral therapy, or utilizing novel treatment approaches. The authors synthesize state-of-the-art treatment and give practical advice for clinicians.


Asunto(s)
Trastorno Obsesivo Compulsivo/terapia , Pirenzepina/análogos & derivados , Antipsicóticos/uso terapéutico , Benzodiazepinas , Terapia Cognitivo-Conductual/métodos , Terapia Combinada , Quimioterapia Combinada , Fluvoxamina/uso terapéutico , Humanos , Morfina/uso terapéutico , Estudios Multicéntricos como Asunto , Inhibidores de la Captación de Neurotransmisores/uso terapéutico , Trastorno Obsesivo Compulsivo/tratamiento farmacológico , Olanzapina , Pirenzepina/uso terapéutico , Guías de Práctica Clínica como Asunto , Estudios Retrospectivos , Literatura de Revisión como Asunto , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Sumatriptán/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...